OtherAbsorption, Distribution, Metabolism, and Excretion
The cytochrome P450 2B6 is the main catalyst of efavirenz primary and secondary metabolism: implication for HIV/AIDs therapy and utility of efavirenz as substrate marker of CYP2B6 catalytic activity
Bryan A. Ward, Christopher J. Gorski, David R. Jones, Stephen D. Hall, David A. Flockhart and Zeruesenay Desta
Journal of Pharmacology and Experimental Therapeutics April 3, 2003, DOI: https://doi.org/10.1124/jpet.103.049601
Bryan A. Ward
Christopher J. Gorski
David R. Jones
Stephen D. Hall
David A. Flockhart
Jump to comment:
No eLetters have been published for this article.
In this issue
OtherAbsorption, Distribution, Metabolism, and Excretion
The cytochrome P450 2B6 is the main catalyst of efavirenz primary and secondary metabolism: implication for HIV/AIDs therapy and utility of efavirenz as substrate marker of CYP2B6 catalytic activity
Bryan A. Ward, Christopher J. Gorski, David R. Jones, Stephen D. Hall, David A. Flockhart and Zeruesenay Desta
Journal of Pharmacology and Experimental Therapeutics April 3, 2003, DOI: https://doi.org/10.1124/jpet.103.049601
OtherAbsorption, Distribution, Metabolism, and Excretion
The cytochrome P450 2B6 is the main catalyst of efavirenz primary and secondary metabolism: implication for HIV/AIDs therapy and utility of efavirenz as substrate marker of CYP2B6 catalytic activity
Bryan A. Ward, Christopher J. Gorski, David R. Jones, Stephen D. Hall, David A. Flockhart and Zeruesenay Desta
Journal of Pharmacology and Experimental Therapeutics April 3, 2003, DOI: https://doi.org/10.1124/jpet.103.049601
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement